[{"address1": "21925 W. Field Parkway", "address2": "Suite 235", "city": "Deer Park", "state": "IL", "zip": "60010-7278", "country": "United States", "phone": "847 787 7361", "website": "https://www.etonpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.", "fullTimeEmployees": 31, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean E. Brynjelsen", "age": 52, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1116640, "exercisedValue": 0, "unexercisedValue": 16187572}, {"maxAge": 1, "name": "Mr. James R. Gruber CPA", "age": 52, "title": "CFO, Treasurer & Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 647849, "exercisedValue": 0, "unexercisedValue": 1195594}, {"maxAge": 1, "name": "Mr. David C. Krempa", "age": 35, "title": "Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 647849, "exercisedValue": 0, "unexercisedValue": 4872540}, {"maxAge": 1, "name": "Ms. Ipek  Erdogan-Trinkaus", "age": 42, "title": "Chief Commercial Officer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 435943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Danka  Radosavljevic", "title": "Executive Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Grossenbach", "title": "Senior Vice President of Sales Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.25, "open": 18.14, "dayLow": 17.7, "dayHigh": 18.53, "regularMarketPreviousClose": 18.25, "regularMarketOpen": 18.14, "regularMarketDayLow": 17.7, "regularMarketDayHigh": 18.53, "payoutRatio": 0.0, "beta": 1.16, "forwardPE": 33.981133, "volume": 152285, "regularMarketVolume": 144219, "averageVolume": 298939, "averageVolume10days": 185370, "averageDailyVolume10Day": 185370, "bid": 17.96, "ask": 18.12, "bidSize": 1, "askSize": 1, "marketCap": 482983840, "fiftyTwoWeekLow": 8.24, "fiftyTwoWeekHigh": 23.0, "allTimeHigh": 23.0, "allTimeLow": 1.95, "priceToSalesTrailing12Months": 8.301401, "fiftyDayAverage": 18.7052, "twoHundredDayAverage": 16.348, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 488297792, "profitMargins": -0.07095, "floatShares": 17961044, "sharesOutstanding": 26817535, "sharesShort": 3020407, "sharesShortPriorMonth": 3647734, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1126, "heldPercentInsiders": 0.04388, "heldPercentInstitutions": 0.62321997, "shortRatio": 8.27, "shortPercentOfFloat": 0.1184, "impliedSharesOutstanding": 27160013, "bookValue": 0.893, "priceToBook": 20.167973, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -4128000, "trailingEps": -0.15, "forwardEps": 0.53, "enterpriseToRevenue": 8.393, "enterpriseToEbitda": 107.602, "52WeekChange": 1.1568863, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 18.01, "targetHighPrice": 35.0, "targetLowPrice": 26.0, "targetMeanPrice": 30.0, "targetMedianPrice": 29.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 25379000, "totalCashPerShare": 0.946, "ebitda": 4538000, "totalDebt": 30693000, "quickRatio": 1.032, "currentRatio": 1.773, "totalRevenue": 58181000, "debtToEquity": 128.096, "revenuePerShare": 2.199, "returnOnAssets": 0.01832, "returnOnEquity": -0.22061001, "grossProfits": 36912000, "freeCashflow": -13506125, "operatingCashflow": 12236000, "revenueGrowth": 1.086, "grossMargins": 0.63443, "ebitdaMargins": 0.078, "operatingMargins": -0.01416, "financialCurrency": "USD", "symbol": "ETON", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.31507, "regularMarketPrice": 18.01, "shortName": "Eton Pharmaceuticals, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1542119400000, "postMarketChangePercent": -0.20655707, "postMarketPrice": 17.9728, "postMarketChange": -0.037200928, "regularMarketChange": -0.24, "regularMarketDayRange": "17.7 - 18.53", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 298939, "fiftyTwoWeekLowChange": 9.77, "fiftyTwoWeekLowChangePercent": 1.1856797, "fiftyTwoWeekRange": "8.24 - 23.0", "fiftyTwoWeekHighChange": -4.99, "fiftyTwoWeekHighChangePercent": -0.21695651, "fiftyTwoWeekChangePercent": 115.68864, "earningsTimestamp": 1762459200, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1762464600, "earningsCallTimestampEnd": 1762464600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.15, "epsForward": 0.53, "epsCurrentYear": 0.48, "priceEpsCurrentYear": 37.520836, "longName": "Eton Pharmaceuticals, Inc.", "cryptoTradeable": false, "fiftyDayAverageChange": -0.69519997, "fiftyDayAverageChangePercent": -0.037166134, "twoHundredDayAverageChange": 1.6620007, "twoHundredDayAverageChangePercent": 0.10166386, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "postMarketTime": 1761952752, "regularMarketTime": 1761940802, "exchange": "NGM", "messageBoardId": "finmb_435353222", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Eton Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]